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A b s t r a c t 
Background: The frequency of arrhythmic death developing without a structural cardiac disease is higher in women. Also, 
female sex is an independent risk factor regarding development of torsades de pointes. Several studies have been conducted 
on the physiological and therapeutic effects of sex hormones on the cardiac conduction system. 
Aim: In this study we aim to examine the effect of hormonal changes, especially supraphysiological E2 level changes occurring 
during in vitro fertilisation treatment, on ventricular repolarisation parameters.
Methods: The study included female patients aged between 23 and 39 years, who were administered controlled ovarian 
hyperstimulation treatment. Patients’ electrocardiograms and blood samples were obtained and analysed before and after 
the ovarian hyperstimulation treatment.
Results: Mean QTc intervals before ovarian hyperstimulation were 411.9 ± 23.7 ms. Measurements during oestradiol peak were 
calculated as 420.7 ± 23.3 ms, and the QTc interval increase was significant (p = 0.007). Corrected QT dispersion averages 
were not significant before or after hyperstimulation (53 ± 17 ms vs. 54.5 ± 18.2 ms, respectively, p > 0.05). Tp-e, J-T peak, 
and PR dispersion changes were not significant after the ovarian hyperstimulation therapy.
Conclusions: Supraphysiological oestradiol levels that occur during controlled ovarian hyperstimulation cause prolongation of 
QTc intervals, but not to a pathological level. Although this prolongation is not significant in healthy individuals, it might increase 
ventricular arrhythmia risk in patients with congenital long QT syndrome and in patients taking medication that prolongs QT.
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INTRODUCTION
Sudden cardiac deaths (SCDs) make up 10% to 15% of natural 
deaths. The majority of SCDs develop in individuals who have 
structural cardiac diseases such as coronary artery disease and 
cardiac insufficiency. Even with a structural cardiac disease, 
the reason for SCD is fatal ventricular arrhythmia such as 
ventricular tachycardia and ventricular fibrillation. Although 
it is often seen in men, the frequency of arrhythmic death 
developing without a structural cardiac disease is higher in 
women [1]. It has been shown in numerous studies that female 
sex is an independent risk factor regarding development of 
torsades de pointes (TdPs), which is a fatal arrhythmia [2]. 
A lot of studies have been carried out recently to find out 
the reasons for this increased arrhythmic case risk in women. 
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Individuals with prolonged cardiac repolarisation carry the risk 
of developing fatal ventricular arrhythmia. Prolonged action 
potential usually occurs due to prolonged cardiac repolarisa-
tion. Prolongation in QT interval, which is the equivalent of 
action potential duration in an electrocardiogram (ECG), is 
a significant electrocardiographic predictive indicator of fatal 
ventricular arrhythmias. The effect of sex hormones on cardiac 
action potential and ECG has been shown in studies carried 
out in animals and humans. In these studies it was revealed 
that endogen testosterone and progesterone shorten QT 
interval, whereas oestrogen prolongs QT interval [3]. Also, 
it was shown that hormonal fluctuations occurring during 
menstrual cycle do not have a direct effect on QT interval 
duration [4]. However, women were shown to be more sensi-
tive during menstruation and ovulation periods compared to 
men regarding QT prolongation induced with ibulitide [5]. 
This gives rise to the thought that progesterone, which peaks 
in the luteal phase, protects drug-induced QT prolongation 
related to oestrogen in women. In studies that examined the 
effects of hormone replacement treatments (HRT) applied to 
postmenopausal women, it was shown that HRT involving 
oestrogen only caused prolongation of QT interval. However, 
HRT that involves both oestrogen and progesterone does not 
have an effect on QT interval [6].
In vitro fertilisation (IVF) is administered to about 1.5 mil-
lion infertile women who want to get pregnant all around the 
world every year. E2 increase to supraphysiological levels may 
also be due to the effect of exogenic gonadotropins admin-
istered to patients during IVF. 
While E2 levels fluctuate between 27 and 123 pg/mL 
(in the follicular phase) and between 96 and 436 pg/mL (in 
the luteal phase) during a normal menstruation cycle, E2 lev-
els rise to 4000 pg/mL due to gonadotropins administered 
in IVF treatment. These levels are much higher than both 
physiological limits and levels that can be reached with HRT 
administered in the postmenstrual period. In this study we aim 
to examine the effect of hormonal changes occurring during 
IVF treatment, and especially supraphysiological E2 levels, on 
ventricular repolarisation parameters. Thus, it will be revealed 
whether gonadotropins administered to patients during IVF 
treatment increase TdP risk via supraphysiological E2 levels, 
and whether oestrogen level has an effect on cardiac repo-
larisation parameters.  
METHODS
This study was carried out in patients who applied to Zeynep 
Kamil Maternity and Children’s Training and Research Hospital 
for infertility treatment between September and December 
2014. The study included female patients aged between 23 and 
39 years, who were administered controlled ovarian hyper-
stimulation treatment. Inclusion criteria were the absence of 
abnormalities in cardiac examination, bio-chemical laboratory 
investigations, and myocardial repolarisation parameters.
However, patients who were obese (body mass in-
dex > 30 kg/m2), were taking medication other than infertility 
medication, had a sudden cardiac death history in the family, 
and were diagnosed with a known chronic disease (diabetes 
mellitus, hypertension, etc.) were excluded from the study.
The study was approved by the Ethics Committee of 
Zeynep Kamil Maternity and Children’s Training and Research 
Hospital (Istanbul, Turkey), and all subjects gave written, 
informed consent to participate.
Study protocol
Patients’ regular physical examinations and laboratory tests 
were done in Zeynep Kamil Maternity and Children’s Training 
and Research Hospital. ECG and blood sampling were per-
formed twice in each patient: before ovarian hyperstimulation 
treatment (while oestradiol was < 50 pg/mL) and when the 
follicle was developed and was available for human chorionic 
gonadotropin. Blood samples were taken between 8.30 and 
9.30 a.m. in the same setting and under the same circum-
stances. In order to prevent diurnal changes in QT interval, 
ECG was done on the same day at about 10 a.m. following 
bloodletting. ECG was done in the same room with patients 
after taking a 20-min rest in the supine position. ECG was 
performed at a paper speed of 50 mm/s and with 20 mm/mV 
amplitude. All ECG results were codified and recorded. Car-
diologists who were blind to the coding system examined 
the ECG results and performed manual measurements. ECG 
samples were scanned and computerised, and digital meas-
urements were done. All measurements were recorded by 
calculating the average of three successive beats.
ECG measurements and repolarisation parameters
The QT interval is the distance between the beginning of the 
QRS complex and the return of the T wave to the isoelectric 
line. QT interval represents the periods of ventricular depolari-
sation and repolarisation phases. QT-interval measurements 
were done from lead II in three successive beats from the 
beginning of the RS wave to the end of the T wave. Cases 
where the end of the T wave could not be determined were 
excluded from the study. If there was a U wave in the lead, 
the bottom point of the segment between the T and U waves 
was assumed as the end of the T wave [7]. The average QT 
interval was calculated in milliseconds.
QT dispersion was calculated as the difference between 
the longest and shortest QT interval on a 12-lead ECG. 
QTc interval and QTd were calculated with heart rate cor-
rection of the QT interval and QTd using Bazett’s formula 
(QTc = QT√RR) [8]. 
J-T peak interval, from the J point to the T-wave peak, 
was measured for early repolarisation assessment; it reflects 
the early repolarisation phase of action potential. Tpeak-Tend 
(Tp-e) is the distance between T-wave peak point and the 
returning point to the isoelectric line. Tp-e represents late 
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phase of action potential. PR dispersion was obtained by 
subtracting minimum PR distance from maximum PR distance 
in a 12-lead ECG, calculated in milliseconds.
Statistical analysis
Statistical analyses were done using SPSS 11 software 
(SPSS Inc., Armonk, NY, USA). Categorical variables were 
expressed as numbers and percentages, and continuous 
variables were expressed as the mean ± standard deviation. 
Kolmogorov-Smirnov test was used to determine whether 
the data followed normal distribution. Comparisons between 
the groups were performed using  paired t test or Wilcoxon 
signed-rank test, as appropriate. P values < 0.05 were ac-
cepted as significant.
RESULTS
Demographic features and laboratory findings 
A total of 59 female patients who were administered IVF 
treatment and controlled ovarian hyperstimulation in Zeynep 
Kamil Maternity and Children’s Training and Research Hos-
pital were included in the study. Clinical characteristics and 
laboratory findings of the patients are presented in Table 1. 
Mean values of laboratory investigations were within the 
reference ranges. 
Oestradiol levels
Oestrogen levels of the patients before administering ovarian 
hyperstimulation were 47 ± 30 pg/mL, whereas after ovarian hy-
perstimulation they were 1656 ± 878 pg/mL (p < 0.001; Fig. 1).
Electrocardiographic repolarisation parameters
Regarding corrected QT, QTc measurements were done in 
DII, V2, and V5 derivations, which yield the clearest measure-
ments on 12-lead ECG. Mean QTc intervals before ovarian 
hyperstimulation were 411.9 ± 23.7 ms, 418.6 ± 23.2 ms, 
and 411.1 ± 20.1 ms, respectively. Measurements at the 
same derivations during oestradiol peak were calculated as 
420.7 ± 23.3 ms, 426.3 ± 27 ms, and. 418.7 ± 24.1 ms, 
respectively, and the prolongation of QTc intervals was signifi-
cant for each derivation (p = 0.007, p = 0.02, and p = 0.01, 
respectively, Fig. 2). However, QTc values obtained after this 
prolongation were still within the normal range.
QT dispersions before hyperstimulation were 46 ± 14 ms, 
whereas these were measured as 45.8 ± 15 ms during E2 peak 
(p > 0.05). Similarly, corrected QT dispersion averages were 
not significant before or after hyperstimulation (53 ± 17 ms 
vs. 54.5 ± 18.2 ms, respectively, p > 0.05). 
Regarding Tp-e and J-T peak, although there was no 
significant difference, Tp-Te values were prolonged after 
the hyperstimulation (75.4 ± 10.4 ms vs. 78.2 ± 9.3 ms, 
respectively, p > 0.05). J-T peak values, which indicate 
early repolarisation, were found to be significantly shortened 
(203.9 ± 25.3 ms vs. 196.4 ± 29.1 ms, p = 0.002; Fig. 2).
Regarding PR dispersion, while average PR dispersion 
before hyperstimulation was 33.3 ± 11.3 ms, it was found to 
be 30.8 ± 10.5 ms after hyperstimulation, and this was not 
a significant difference (p > 0.05). 
DISCUSSION
This study shows that QTc interval was prolonged with su-
praphysiological oestradiol levels after controlled ovarian 
hyperstimulation. This prolongation was consistent in all three 
ECG derivations. Therefore, it was concluded that oestradiol 
peak in IVF treatment increased QTc interval prolongation and 
Table 1. Clinical characteristics and laboratory findings of the 
study population
Number 59
Age [years] 31.8 ± 4.4
WBC [×103 µL] 7.7 ± 1.8
Haemoglobin [g/dL] 12.8 ± 1.0
Platelet [×103 µL] 264 ± 52
Serum urea [mg/dL] 10.1 ± 2.8
Mg [mg/dL] 1.96 ± 0.1
K [mEq/L] 4.2 ± 0.3
Ca [mg/dL] 9.5 ± 0.5
Basal FSH [mlU/mL] 6.6 ± 3.1
Basal TSH [mlU/mL] 2.1 ± 1.2
Data are given as mean ± standard deviation. WBC — white blood 
cell; Mg — magnesium; K — potassium; Ca — calcium; FSH — follicle 
stimulating hormone; TSH — thyroid stimulating hormone
Figure 1. Oestradiol levels after logarythmic transformation 
before and after controlled ovarian hyperstimulation
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therefore risk of arrhythmia. To the best of our knowledge, 
this is the first study that describes the effect of ovarian hy-
perstimulation on QTc interval prolongation. We found one 
English study in which ECG changes were examined after 
ovulation induction. Uckuyu et al. [9] found that QTc inter-
val did not change with ovulation induction. Therefore, our 
results are different from those reported by Uckuyu et al. [9]. 
The reason for this inconformity may originate from either 
the fact that oestradiol levels in the mentioned study were 
lower (684.1 ± 219.8 pg/mL vs. 1656 pg/mL ± 878 pg/mL, 
respectively) or that ECG measurements were done manually. 
The QT interval is longer in premenopausal women 
compared to men [8]. Also, the QT interval is longer in 
women, despite the higher heart rates that shorten QT inter-
val. Moreover, women tend to develop TdP when exposed to 
medication that prolongs the QT interval [10]. Also, female sex 
is an independent risk factor for syncope and sudden death in 
patients with congenital long QT syndrome [11]. Differences in 
QT interval between the sexes begin in puberty and end in the 
postmenopausal period. QT shortens in men in puberty, and 
similarly men after orchiectomy have longer QT compared to 
other men [12]. In addition, QT intervals in women with viri-
lisation were found to be shorter compared to other women.
Study results regarding QT interval changes during men-
strual cycle are inconsistent. In general, although it is possible 
to say that the QT interval does not change during the men-
strual cycle [13], some studies showed that the QT interval 
shortened while progesterone levels were high in the luteal 
phase [14]. Also, it was shown that in the case of exposure 
to medication that prolonged QT, greater QT prolongation 
occurred in women in the ovulatory phase compared to 
women in the luteal phase [4]. The fact that progesterone level 
and progesterone/oestradiol rate is inversely proportional to 
drug-related QT prolongation might show that progesterone 
has a protective role [4, 15]. These studies also support the 
theory that oestrogen prolongs QT interval whereas proges-
terone shortens it.
Studies on the effects of oestrogen replacement treat-
ment on QT in postmenopausal women are contradictory. 
Although there are many studies pointing out that oestrogen 
replacement treatment does not have an effect on QT [16, 
17], Gökçe et al. [6] reported that in long-term replacement 
treatment the QT interval was prolonged, and they revealed 
that when combined with progestin, this effect was not ob-
served. Similarly, Haseroth et al. [18] showed that the QT 
interval was prolonged in oestrogen treatment.
We found in our study that QTc interval prolongation 
varied between 7.6 and 8.8 ms. These values were within 
the reference range; therefore, it is hard to assess their effect 
on the risk of arrhythmia. It would be important to examine 
these parameters in future in patients requiring IVT treatment 
who have long QT syndrome or whose QT intervals are dose 
to abnormal values.
In our study there was no significant change regarding 
supraphysiological oestradiol levels in terms of QT dispersion 
and corrected QT dispersion. Also, in the study in which we 
compared hormonal changes during physiological menstrual 
cycle and ECG and 24-h Holter ECG findings, there was no 
correlation between ovulation and QT dispersion [19]. There 
are also other studies showing that there is no significant rela-
tion between menstrual cycle and QT dispersion [4]. The data 
regarding QT dispersion were not consistent with the study 
carried out by Uckuyu et al. [9]. In their study QT dispersion 
was shown to have decreased with ovulation. This difference 
might result from about a threefold difference in oestradiol 
levels or different measurement methods.
In this study the Tp-e interval, an indicator of electri-
cal heterogeneity and late repolarisation, was found to be 
slightly prolonged, but the increase did not reach statistical 
significance. Myocardium is composed of three different 
Figure 2. Electrocardiography measurements before and after in vitro fertilisation (IVF) therapy
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myocyte types: endocardial, epicardial, and midmyocardial 
M cells [20]. Although these layers are morphologically similar, 
they exhibit different electrophysiological characteristics. For 
instance, midmyocardial M cells have the longest action 
potential duration. Some studies point out a relationship be-
tween Tp-e and ventricular arrhythmia, cardiac insufficiency, 
and sudden cardiac death [21]. Tp-e prolongation represents 
a potential liability to reentrant arrhythmia. Also, previous 
studies have shown that transmural repolarisation dispersion 
might predict arrhythmic cases in Brugada, short QT, and long 
QT syndromes [20]. Again, some studies have revealed that 
in clinical cases such as obstructive sleep apnoea, chronic 
arsenic exposure [22] and ST-elevated myocardial infarction 
[20] transmural dispersion of repolarisation increase, and in 
patients with stable coronary artery disease, they decrease 
with the increase in the collateral circulation [23].
J-T peak interval is an early repolarisation parameter 
that was found to be shortened during the oestradiol peak. 
These data are concordant with our previous study on the 
physiological cycle [19]. This finding suggests that calcium ion 
influx currents (responsible for early repolarisation) may be 
affected by hormonal changes. Calcium channel inhibitory ef-
fects of oestrogen have been shown in some studies [24]. The 
shortening of J-T peak supports the theory that oestradiol may 
have a protective effect against early repolarisation-related 
arrhythmia and may increase the risk of late repolarisation 
abnormalities. 
PR dispersion was shown to be prolonged in atrial fibril-
lation, hypertension, diabetes mellitus, and cardiovascular 
disease [25]. In our study, we found out that there was no 
relationship between supraphysiological oestradiol levels and 
PR interval. Hence, it might be assumed that a supraphysi-
ological oestradiol level is not associated with elevated risk 
of arrhythmia, including atrial fibrillation. To the best of our 
knowledge, this is the first study that shows the effect of female 
sex hormones on PR dispersion. However, more comprehen-
sive studies are necessary in this topic. 
In conclusion, supraphysiological oestradiol levels that 
occur during controlled ovarian hyperstimulation cause 
prolongation of QTc interval, though not to a pathological 
level. Although this prolongation is not significant in healthy 
individuals, it might increase the risk of ventricular arrhyth-
mia in patients with congenital long QT syndrome and in 
patients taking medication that prolongs QT. For this reason, 
it is appropriate to investigate family history and medication 
history of patients who will be administered controlled ovarian 
hyperstimulation, in terms of developing arrhythmia.
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